St. Louis, Mo., February 9, 2010 - Novus International, Inc. announced today they have completed the acquisition of the Animal Nutrition Division of Albion Laboratories Inc, a company based in Clearfield, UT. Terms of the deal were not disclosed.
Products from the acquisition, including the MAAC (R) chelated trace mineral product line, will align with Novus's MINTREX® and GLYTREX® chelated trace mineral products and further expand Novus's mineral technology. This acquisition will enable Novus to offer a broader range of products to address the needs of different customers in different parts of the world to support their livestock operations.
Since its establishment in 1956, Albion has been an innovator in mineral chelate nutrition. Albion manufactures highly bioavailable, research based, nutritional chelated trace mineral forms and has a long-standing customer base in both the beef and dairy markets.
Geographically, Albion is primarily present in the animal organic trace mineral industry in the U.S., Europe, Canada, the Middle East and Japan. The combined geographic and market presence will provide Novus the opportunity to offer new customers a wider range of health and nutritional products, programs and solutions.
"We are very excited to support our customers by expanding and incorporating these high quality products into our portfolio," explained Giovanni Gasperoni, Executive Vice President, Sales and Marketing, Novus International. "Specifically, the Albion product offering will increase the breath and reach of our MINTREX® and GLYTREX® chelated trace mineral technologies."
Novus's current products include amino acids, chelated trace minerals, feed preservatives, and other nutrition and health products for the animal agriculture, companion animal, human and industrial markets. Key areas of focus include helping customers increase the supply of animal protein to meet global demands, sustainable agriculture practices, use of local by-products, food safety, animal welfare, and animal health and nutrition.